Mental Health Residential Treatment: How to Appeal the "Acute" vs "Subacute" Coverage Cut

Day seven of the admission, the carrier nurse reviewer on the morning concurrent-review call used the word "subacute." Day six, the same reviewer had used the word "acute." Nothing about the patient's clinical picture had moved between those two calls. The 17-year-old at a residential treatment facility outside Asheville, North Carolina, had been admitted for severe major depressive disorder with active suicidal ideation following two emergency department visits in the prior 11 days. The treating psychiatrist's progress notes for day six and day seven were nearly identical: persistent suicidal ideation with plan, ongoing supervision protocol, no readiness for step-down to partial hospitalization. The carrier's denial letter, sent that afternoon to the patient's mother, said the level of care was no longer medically necessary because the patient's presentation had "stabilized to a subacute level appropriate for partial hospitalization program." The mother spent the next four hours on hold with the carrier. The treating team spent the next two days writing a continued-stay appeal. The patient stayed at the facility on a single-case-agreement basis with the family paying $4,200 out of pocket for the disputed days while the appeal moved forward.

The acute-to-subacute language is the most common shape of a residential mental health denial. It is also the place where carrier medical-necessity criteria most frequently diverge from the generally accepted standards of care. The American Society of Addiction Medicine criteria, the LOCUS and CALOCUS instruments, and the federal parity framework all bear on whether the carrier's call is a clinically defensible level-of-care judgment or a documentation-defect masquerading as one. The 2024 MHPAEA Final Rule, the Wit v. United Behavioral Health precedent, and the standard ASAM-criteria continued-stay framework supply the material for the appeal.

This article walks through the residential mental health coverage architecture (acute inpatient, residential, partial hospitalization, intensive outpatient, outpatient), the carrier criteria typically applied, the generally accepted-standards alternative the appeal anchors on, the parity overlay that runs in parallel, and the continued-stay and step-down appeal structure that recovers coverage in many cases. It is a companion to the MHPAEA parity article (number 13 in this corpus).

The level-of-care architecture

Mental health and substance use disorder treatment in the United States is organized into a continuum of care defined by acuity and structure. The principal levels:

Acute inpatient psychiatric care, 24-hour locked or unlocked psychiatric unit, typically billed under DRG-based hospital reimbursement. Used for patients in acute crisis with active safety concerns and need for medical stabilization.

Residential treatment, 24-hour structured non-hospital setting providing therapeutic milieu, daily psychiatric care, group therapy, family work, and often educational components for adolescents. Typically billed per diem.

Partial hospitalization program (PHP), structured day program, typically 5 to 6 hours per day, 5 days per week, with full clinical team. Patient lives at home or in community-based housing.

Intensive outpatient program (IOP), structured program typically 9 to 15 hours per week across 3 or more days. Patient lives at home.

Outpatient, traditional individual and group therapy plus medication management.

The level of care a patient receives is a clinical judgment based on acuity, function, support, comorbidity, and response to prior treatment. The American Society of Addiction Medicine (ASAM) criteria, particularly the ASAM Criteria Third Edition (2013) for substance use disorder and the ASAM Criteria Fourth Edition (2023) where applicable, provide the most widely accepted level-of-care framework for SUD treatment. For mental health, the LOCUS (Level of Care Utilization System) for adults and the CALOCUS-CASII for children and adolescents are the principal instruments. The Joint Commission and CARF accreditation standards address the operational and clinical structure at each level.

The "subacute" denial pattern, in concrete terms

The acute-to-subacute denial typically takes one of two procedural shapes. The first is a prior-authorization denial issued before or near the start of treatment, asserting that the requested level of care is not necessary because the patient's presentation can be managed at a lower level. The second is a concurrent-review or continued-stay denial issued during treatment, asserting that the patient's presentation has stabilized to a level appropriate for step-down.

Both denials cite internal medical-necessity criteria. The criteria most frequently used by commercial carriers in this area are internally developed criteria, in some cases the MCG Care Guidelines (formerly Milliman), in some cases the InterQual criteria, and in some cases proprietary plan-developed criteria. Each carrier publishes its own bulletin describing which criteria it applies.

The leverage point for appeal is the comparison between the internally applied criteria and the generally accepted standards of care. Where the internal criteria are stricter than ASAM, LOCUS, or society guidance, the appeal cites the divergence directly. Where the criteria are applied without proper consideration of the patient's individual presentation, the appeal cites the documentation defect. Where the criteria are applied differently to behavioral health than to comparable medical-surgical levels of care, the appeal invokes MHPAEA parity (cross-reference article 13).

What the carriers actually do, and what the law actually requires

The clearest articulation of the gap between carrier criteria and the generally accepted standards of care is Wit v. United Behavioral Health, the federal district court decision finding that United Behavioral Health had applied internal level-of-care criteria more restrictive than the generally accepted standards of care and had used those criteria to deny medically necessary treatment to tens of thousands of plan participants. The Ninth Circuit's 2023 treatment narrowed the remedy on procedural grounds but did not disturb the trial court's factual findings about the gap between carrier criteria and the standards of care.

The Wit framework supplies the appeal anchor. A denial that applies internal criteria more restrictive than the generally accepted standards of care is procedurally vulnerable. The framework was developed in the context of UBH but applies as persuasive authority across the federal court system in behavioral health appeals.

The 2024 MHPAEA Final Rule at 89 Fed. Reg. 77586 added the comparative-analysis document right, which a participant invokes by request under 29 CFR 2590.712(d)(3) for ERISA plans, 45 CFR 146.136(c)(4) for non-ERISA group plans, or 45 CFR 147.160 for individual market plans. The comparative analysis must address each non-quantitative treatment limitation (including medical-necessity criteria, prior-authorization processes, and concurrent-review processes) and demonstrate parity with the comparable limitations applied to medical and surgical benefits in the same classification. A failure to produce the comparative analysis, or a comparative analysis that demonstrates non-parity, becomes appeal evidence.

The parallelism examples are straightforward. Where a plan applies concurrent review every three days to residential mental health treatment but does not apply comparable concurrent review to skilled nursing facility care, the parity question is open. Where a plan applies LOCUS scoring as a strict denial gate for higher levels of mental health care but does not apply a comparable instrument as a strict denial gate for higher levels of medical care, the parity question is open. Where a plan caps residential treatment stays at a fixed number of days but does not impose a comparable cap on inpatient rehabilitation after a qualifying medical event, the parity question is open.

Exhibit 1: The level-of-care continuum, with parity benchmarks

The mental health continuum has medical-surgical analogs at most levels, which is the structural basis for the parity analysis.

| Mental health level | Description | Medical-surgical analog | Typical parity question | |---|---|---|---| | Acute inpatient psychiatric | 24-hour locked or unlocked psychiatric admission | Acute medical inpatient admission | Concurrent-review cadence; LOS authorization | | Residential treatment | 24-hour structured non-hospital therapeutic setting | Inpatient rehabilitation facility (IRF); skilled nursing facility after qualifying stay | Length-of-stay caps; concurrent review | | Partial hospitalization program | 5-6 hours daily, 5 days weekly | Comprehensive outpatient rehabilitation facility (CORF) day program | Frequency caps; concurrent review | | Intensive outpatient program | 9-15 hours weekly, 3+ days | Outpatient cardiac rehabilitation phase II | Session caps; per-diem coverage | | Outpatient therapy | Weekly to twice-monthly | Outpatient PT/OT | Session caps; visit limits | | Medication management | Periodic psychiatric visits | Periodic specialist medical visits | Visit cap parallelism |

Action title for designer: "Most mental health levels of care have medical-surgical analogs. Where the carrier applies a non-quantitative treatment limitation to the mental health level but not the analog, the parity question is open."

Exhibit 2: ASAM, LOCUS, and CALOCUS as the generally accepted framework

The clinical assessment instruments are public, documented, and society-endorsed. The appeal cites them by name.

| Instrument | Population | Use in appeal | |---|---|---| | ASAM Criteria 3rd/4th Edition | Substance use disorder, all ages | Level-of-care recommendation for SUD; six-dimension biopsychosocial assessment | | LOCUS | Adult mental health | Level-of-care recommendation; six-dimension scoring instrument | | CALOCUS-CASII | Child and adolescent mental health | Level-of-care recommendation; eight-dimension scoring instrument | | ECSII | Early childhood mental health | Level-of-care recommendation for very young children | | ASAM 6 Dimensions | Substance use, integrated with above | Acute intoxication, biomedical, emotional/cognitive, readiness, relapse risk, recovery environment |

Action title for designer: "The level-of-care instruments are public. The carrier's job is to apply them faithfully. The appeal's job is to document that the carrier did not."

Exhibit 3: The continued-stay appeal framework

The continued-stay or step-down denial follows a recognizable pattern, and the appeal follows a recognizable response pattern.

| Element | Documentation source | Use in appeal | |---|---|---| | Initial level-of-care rationale | Admission orders, intake assessment | Establishes the clinical basis for the level of care chosen | | Current acuity | Progress notes, day-by-day | Establishes the patient's actual presentation on the disputed day | | ASAM/LOCUS/CALOCUS scoring | Treating team's instrument scoring | Documents the level of care the instruments support | | Safety considerations | Documented suicidal ideation, self-harm history, supervision protocol | Establishes the safety basis for current level | | Step-down readiness criteria | Treating team's assessment of readiness | Documents that step-down criteria are not met | | Comparable medical-surgical limitation | Plan's general concurrent-review practice | Supports parity analysis | | Comparative analysis (if requested) | Carrier's MHPAEA documentation | Supports parity analysis if produced; supports non-production claim if not |

Action title for designer: "The continued-stay appeal is a clinical-record appeal first and a parity appeal second. Both elements belong on the same letter, in the same envelope, with the same deadline."

Why the work is heavier than it appears

Residential mental health appeals layer three frameworks at once: the clinical-record argument (drawn from progress notes, LOCUS/CALOCUS scoring, safety documentation), the Wit-anchored standards-of-care argument, and the MHPAEA parity overlay. Each runs on its own evidentiary record and its own demand letter, and each survives independently of the others if any one is rejected. The mapped library Apellica has catalogued (more than two hundred carrier-by-denial-type cells, indexed at the bulletin level) each interpret ASAM, LOCUS, and CALOCUS through different behavioral-health subcontractors (Optum, Magellan, Carelon, internal), and the medical-necessity criteria applied (MCG, InterQual, proprietary) vary by carrier.

The 30-day MHPAEA comparative-analysis request under 29 CFR 2590.712(d)(3) compels production of the carrier's parity documentation. The 72-hour expedited window for continued-stay denials requires a treating-physician attestation drafted to the carrier's specific urgency standard. Procedural exhaustion missteps foreclose external review. The 42 CFR Part 2 confidentiality framework structures how SUD records are disclosed.

The family is often coordinating treatment for a teen or adult in active crisis at the same time as the carrier nurse reviewer is moving the case toward step-down on a tight clinical clock. The reviewer reads continued-stay appeals all day. The family is writing one.

Day six was "acute." Day seven was "subacute." The progress notes between them were nearly identical. The word that changed was on the carrier's call sheet.

What Apellica brings that a patient cannot

Apellica's senior reviewers maintain the carrier-by-denial-type intelligence database, indexed at the bulletin level across more than two hundred cells, that tracks behavioral-health continued-stay and step-down patterns at every major carrier and behavioral-health subcontractor in the United States. The desk maintains the Wit precedent library, the ASAM/LOCUS/CALOCUS scoring framework, and the current MHPAEA Final Rule implementation guidance.

Same-day document-request and MHPAEA comparative-analysis demand letters go out with the correct CFR cite. Apellica's senior reviewers build the four-part evidence stack, plan-language citation, clinical facts drawn from the treating team's notes and instrument scoring, peer-reviewed and society evidence, regulatory hook combining 29 USC 1185a, the 2024 Final Rule, and Wit, for every case. The 42 CFR Part 2 confidentiality framework is preserved throughout for SUD cases. Expedited handling is requested for ongoing-treatment cases. A senior reviewer reads every appeal before it goes out.

Initial review is free. There is no upfront fee. Families are not asked to pay anything until the carrier reverses the denial.

The Section 1262 SUPPORT Act overlay for SUD residential

For substance use disorder residential treatment, the Section 1262 amendments contained in the SUPPORT for Patients and Communities Act of 2018 expanded Medicaid coverage of SUD residential treatment in IMDs (institutions for mental diseases) in specified circumstances. The federal Medicaid framework historically excluded coverage of services to adults in IMDs under 42 USC 1396d(a)(29)(B). The SUPPORT Act and subsequent CMS guidance, including the State Medicaid Director Letter SMD 19-003, expanded the pathway for state Medicaid programs to obtain Section 1115 waivers covering SUD residential treatment under specified conditions.

The patient-side practical implication is that SUD residential denials in Medicaid contexts have a specific federal framework above them. Where the state has a Section 1115 SUD demonstration waiver, the residential level of care should be a covered service consistent with the waiver. Denials within waiver scope are appealable through the fair-hearing process under 42 CFR 431.220.

42 CFR Part 2, the federal confidentiality framework for SUD patient records, structures how documentation is disclosed in SUD appeals. The appeal should be drafted with Part 2 disclosures in mind. The 2024 amendments to Part 2 (effective 2026) align Part 2 more closely with HIPAA for many purposes; the appeal-specific disclosure framework remains distinct.

Procedural deadlines and parallel filings

Mental health residential denials follow the deadlines of the underlying plan. ACA-regulated plans run on the 180-day internal-appeal window under 45 CFR 147.136(b). ERISA self-funded plans run on the 180-day window under 29 CFR 2560.503-1(h). Medicare Advantage runs on the 60-day window under 42 CFR 422.582. Medicaid runs on state-specified fair-hearing timeframes under 42 CFR 431.220.

For ongoing or about-to-occur treatment, expedited handling is essential. The expedite request is in writing and identifies the specific clinical reason the standard timeframe would jeopardize the patient's health, safety, or function. The 72-hour standards under 45 CFR 147.136(b)(2)(ii)(C) (ACA), 42 CFR 422.584 (MA), and the urgent-care framework at 29 CFR 2560.503-1(m)(1) (ERISA self-funded) apply.

The MHPAEA parity complaint runs in parallel. For ERISA plans, the Department of Labor's EBSA accepts parity complaints at askebsa.dol.gov. For non-ERISA plans, the state insurance commissioner or CMS handles the parity complaint depending on the state's enforcement posture (cross-reference article 13). State enforcement quality varies; the state-by-state map in article 13 applies.

State-by-state variation

State law varies significantly in the protections for residential mental health treatment. Several states have enacted statutes requiring coverage of residential treatment at standards-of-care levels. Several have enacted utilization-review reform statutes addressing the concurrent-review process. The Kennedy Forum tracks state parity enforcement and patient protections; parityregistry.org is the principal resource. The state insurance commissioner's office is the authoritative source for the controlling state law.

For ERISA self-funded plans, state mandates are preempted under 29 USC 1144. The federal MHPAEA framework remains. State enforcement is unavailable but state-law facts may be relevant to the parity analysis as evidence of the generally accepted standards of care.

Where to ask for help

The Kennedy Forum and the Kennedy-Satcher Center for Mental Health Equity, at parityregistry.org, maintain the most comprehensive parity-rights resource and a complaint-assistance framework. The National Alliance on Mental Illness HelpLine at 1-800-950-NAMI provides one-on-one navigation. The Legal Action Center, at lac.org, focuses on substance use disorder and confidentiality issues. SAMHSA's National Helpline at 1-800-662-HELP provides 24-hour treatment-referral and information service. The Department of Labor's EBSA at askebsa.dol.gov handles ERISA parity complaints. State insurance commissioners are indexed at content.naic.org/consumer.htm. For Medicaid, state Medicaid offices and state legal-services programs are the principal resources. Apellica, at apellica.com, prepares evidence-based appeal letters for mental health and substance use disorder denials in all 50 states with no upfront fee.

What to do if a family member is in residential treatment and a denial just arrived

The clinical record carries the medical-necessity argument. The standards-of-care framework carries the Wit argument. The parity overlay runs in parallel. Most families leave coverage on the table because layering all three is more procedural work than they can take on while supporting a family member in active treatment.

The Asheville family's continued-stay appeal reached the carrier's behavioral-health medical director on a peer-to-peer call. Authorization extended through day fourteen. The $4,200 the family had paid out of pocket during the appeal window was refunded after the case was reclassified.

What Apellica does

Apellica prepares the evidence-based appeal letter for mental health and substance use disorder treatment coverage denials at every level of care, in all 50 states, at every level of the internal and external appeal process. The patient or family member reviews and approves every word before submission and authorizes carrier communications under a HIPAA-compliant Assignment of Benefits and, where applicable, 42 CFR Part 2 consent. We are not a law firm. We are not a medical provider. We are not an insurance carrier. We are an independent administrative service that turns a denied claim into a properly documented appeal letter.

Our model is $0 upfront and a flat fee on successful recovery. If the appeal does not reverse, the patient owes nothing for the preparation work. Coverage extends to all 50 states, every commercial carrier, ERISA plans, Medicare Advantage, Medicaid, TRICARE, and VA. A senior reviewer reads every case before it goes out.

About the author

The author, Mark Henderson, reviews insurance-denial appeals at Apellica, an independent administrative service that operates out of One World Trade Center, Suite 8500, in New York. Apellica works in all fifty states. The service does not practice law, does not provide medical care, and does not underwrite insurance. Questions go to press@apellica.com or +1 (888) 777-6120. The website is apellica.com.

References

• Mental Health Parity and Addiction Equity Act of 2008, 29 USC 1185a.
• 89 Fed. Reg. 77586 (Sept. 23, 2024). MHPAEA Final Rule.
• 29 CFR 2590.712. ERISA implementation of MHPAEA.
• 29 CFR 2590.712(d)(3). Comparative analyses of NQTLs.
• 45 CFR 146.136. PHSA group market implementation of MHPAEA.
• 45 CFR 147.160. Individual market implementation of MHPAEA.
• 45 CFR 147.136. Internal claims and appeals and external review.
• 29 CFR 2560.503-1. ERISA claims procedure.
• Wit v. United Behavioral Health, 2019 WL 1033730 (N.D. Cal. Mar. 5, 2019).
• Wit v. United Behavioral Health, 79 F.4th 1029 (9th Cir. 2023).
• ASAM Criteria, Third Edition (2013) and Fourth Edition (2023).
• LOCUS (Level of Care Utilization System for Adults).
• CALOCUS-CASII (Child and Adolescent Level of Care/Service Intensity).
• Section 1262 of the SUPPORT for Patients and Communities Act of 2018.
• 42 USC 1396d(a)(29)(B). Medicaid IMD exclusion.
• 42 CFR Part 2. Confidentiality of substance use disorder patient records.
• 42 CFR 422.582. Medicare Advantage reconsideration deadline.
• 42 CFR 422.584. Medicare Advantage expedited reconsideration.
• 42 CFR 431.220. Medicaid fair-hearing procedures.
• 29 USC 1144. ERISA preemption.
• CMS State Medicaid Director Letter SMD 19-003.
• Kennedy Forum and Kennedy-Satcher Center. parityregistry.org.
• National Alliance on Mental Illness. nami.org.
• Legal Action Center. lac.org.
• SAMHSA National Helpline. 1-800-662-HELP.
• Department of Labor, Employee Benefits Security Administration. askebsa.dol.gov.
• NAIC Consumer Information Source. content.naic.org/consumer.htm.